Keita Ishijima

Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants

Saya Moriyama, Yu Adachi, Takashi Sato et al. · Immunity · 2021 · 152 citations · Full text

Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants

Shô Miyamoto, Takeshi Arashiro, Yu Adachi et al. · Med · 2022 · 77 citations · Full text

Vaccination, Vaccine Target, Immunology +6

Zoonotic Infection with Oz Virus, a Novel Thogotovirus

Ngo Thuy Bao Tran, Hiroshi Shimoda, Keita Ishijima et al. · Emerging infectious diseases · 2022 · 35 citations · Full text

A Patient with Severe Fever with Thrombocytopenia Syndrome (SFTS) Infected from a Sick Dog with SFTS Virus Infection

Hiroaki Oshima, Hironobu Okumura, Ken Maeda et al. · Japanese Journal of Infectious Diseases · 2022 · 32 citations · Full text

Viral Diagnostics, Thrombocytopenia Syndrome, Pathology +17

Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants

Shô Miyamoto, Takeshi Arashiro, Yu Adachi et al. · 2022 · 27 citations · Full text

Immunology, Immunodominance, Immune System +16